SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-337326
Filing Date
2017-11-08
Accepted
2017-11-08 16:32:47
Documents
56
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d462258d10q.htm 10-Q 346137
2 EX-31.1 d462258dex311.htm EX-31.1 9109
3 EX-31.2 d462258dex312.htm EX-31.2 9094
4 EX-32.1 d462258dex321.htm EX-32.1 3749
5 EX-32.2 d462258dex322.htm EX-32.2 3776
  Complete submission text file 0001193125-17-337326.txt   2560601

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20170930.xml EX-101.INS 436427
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20170930.xsd EX-101.SCH 38334
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20170930_cal.xml EX-101.CAL 46513
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20170930_def.xml EX-101.DEF 110626
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20170930_lab.xml EX-101.LAB 284886
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20170930_pre.xml EX-101.PRE 196793
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 171187040
SIC: 2834 Pharmaceutical Preparations